CompletedPhase 1NCT00361049
Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Case Comprehensive Cancer Center
- Principal Investigator
- Hillard M. Lazarus, MDIreland Cancer Center at University Hosptials Case Medical Center, Case Comprehensive Cancer Center
- Intervention
- graft versus host disease prophylaxis/therapy(biological)
- Enrollment
- 49 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2004 – 2010
Study locations (8)
- Geauga Regional Hospital, Cleveland, Ohio, United States
- Lake/University Ireland Cancer Center, Cleveland, Ohio, United States
- Ireland Cancer Center at University Hosptials Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
- University Suburban Health Center, Cleveland, Ohio, United States
- UHHS Chagrin Highlands Medical Center, Cleveland, Ohio, United States
- Southwest General Health Center, Cleveland, Ohio, United States
- UHHS Westlake Medical Center, Cleveland, Ohio, United States
- Mercy Cancer Center at Mercy Medical Center, Cleveland, Ohio, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00361049 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.